AC Immune (ACIU) Equity Ratio (2016 - 2025)

AC Immune (ACIU) has disclosed Equity Ratio for 10 consecutive years, with 0.29 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 40.15% to 0.29 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.29 through Dec 2025, down 40.15% year-over-year, with the annual reading at 0.29 for FY2025, 40.15% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.29 at AC Immune, down from 0.49 in the prior quarter.
  • The five-year high for Equity Ratio was 0.91 in Q4 2022, with the low at 0.29 in Q4 2025.
  • Average Equity Ratio over 5 years is 0.69, with a median of 0.88 recorded in 2023.
  • The sharpest move saw Equity Ratio grew 2.43% in 2022, then tumbled 44.67% in 2024.
  • Over 5 years, Equity Ratio stood at 0.89 in 2021, then grew by 2.43% to 0.91 in 2022, then decreased by 3.32% to 0.88 in 2023, then crashed by 44.67% to 0.49 in 2024, then tumbled by 40.15% to 0.29 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.29, 0.49, and 0.88 for Q4 2025, Q4 2024, and Q4 2023 respectively.